Trends and future projections of alcohol-attributable hepatitis B burden in women of childbearing age (1990–2040): a global analysis

Jiaxing Li, Qihui Hu, Jixing Wang, Zhenhao Huang, Hui Cai, Chang Liu, Hao Li, Rui TaoFrontiers in Public Health 2025 · DOI

Abstract: Despite declining age-standardized rates, population growth and alcohol exposure necessitate region-specific interventions. These findings underscore the urgent need for WHO alcohol control policies and HBV birth-dose vaccination in low-SDI regions, particularly sub-Saharan Africa and South Asia, to achieve 2030 elimination targets.

Introduction: The Dual Threat to Women’s Health

Chronic Hepatitis B virus (HBV) infection remains a formidable global health crisis, affecting over 254 million individuals and claiming approximately 1.1 million lives each year. Women of childbearing age (WCBA, ages 15–49) are a particularly vulnerable demographic. They face a "dual threat": the potential for vertical transmission to newborns and the accelerated progression of liver disease—such as cirrhosis and hepatocellular carcinoma—when HBV infection is compounded by alcohol consumption.

Despite the synergistic damage caused by alcohol and HBV, the specific global burden within this demographic has remained poorly quantified. This study analyzes historical trends from 1990 to 2021 and provides projections through 2040 to inform World Health Organization (WHO) elimination strategies.

Methodology

To map this burden, researchers utilized data from the Global Burden of Diseases (GBD) Study 2021, covering 204 countries. The analysis employed several advanced statistical techniques:

  • Joinpoint Regression: To identify significant shifts or "inflection points" in disease trends.
  • Decomposition Analysis: To isolate the effects of population growth, aging, and epidemiological changes.
  • Bayesian Age-Period-Cohort (BAPC) Analysis: To project future mortality and Disability-Adjusted Life Years (DALYs).
  • Comparative Risk Assessment: Quantifying the specific contribution of alcohol (measured in daily grams of ethanol) to HBV progression.

Key Insights: Regional Divergence and the China Success Story

The study reveals a stark contrast between global trends and regional realities. While the global age-standardized mortality rate (ASMR) has decreased, the absolute number of cases continues to rise, driven by population expansion in low-Socio-demographic Index (SDI) regions.

One of the most significant findings is the "remarkable reduction" in burden achieved by China. Through aggressive public health interventions, China’s reduction in alcohol-attributable HBV burden was nearly triple the global average.

Joinpoint regression analysis of alcohol-attributable HBV deaths in China (1990–2021) showing significant declines.

Conversely, low-SDI regions in sub-Saharan Africa and South Asia face a "triple threat":

  1. Low Vaccination Coverage: HBV birth-dose rates are significantly lower than in high-SDI areas.
  2. Diagnostic Delays: Patients often wait over 8 years for a diagnosis, compared to just 2 years in Europe.
  3. Policy Gaps: A lack of national alcohol control frameworks exacerbates the risk.

Global Burden and 2040 Projections

Between 1990 and 2021, the absolute number of global alcohol-related HBV deaths in WCBA rose from 1,457 to 1,552 (a 6.5% increase), while DALYs increased by 7.2%. This occurred despite the global ASMR falling from 0.12 to 0.08 per 100,000. Interestingly, the study identified a transient "rebound" in DALYs between 1999 and 2005, likely linked to economic shocks and rapid urbanization in developing regions.

Global distribution of age-standardized rates (ASR) for deaths (A) and DALYs (B) in 2021, highlighting regional disparities.

Projections through 2040 suggest that without intensified intervention, the absolute burden will continue to climb. The synergy between alcohol and HBV is potent; the study notes that consuming just 10g of alcohol daily (one standard drink) increases the risk of liver cancer by 38% for HBV-positive individuals.

Conclusion and Future Directions

The findings advocate for a "dual-strategy" approach to meet 2030 elimination targets. First, there must be an acceleration of HBV birth-dose vaccinations in low-SDI regions. Second, governments must implement the WHO SAFER framework—including taxation, advertising bans, and restricted alcohol availability—to mitigate the lifestyle factors driving liver disease progression. While the rates are improving, the growing population ensures that the total burden remains a critical priority for global health policy.

Summary updated

Abstract

Despite declining age-standardized rates, population growth and alcohol exposure necessitate region-specific interventions. These findings underscore the urgent need for WHO alcohol control policies and HBV birth-dose vaccination in low-SDI regions, particularly sub-Saharan Africa and South Asia, to achieve 2030 elimination targets.
BibTeX
@inproceedings{li2025trends,
  author = {Jiaxing Li and Qihui Hu and Jixing Wang and Zhenhao Huang and Hui Cai and Chang Liu and Hao Li and Rui Tao},
  title = {{Trends and future projections of alcohol-attributable hepatitis B burden in women of childbearing age (1990–2040): a global analysis}},
  booktitle = {Frontiers in Public Health},
  year = {2025},
  doi = {10.3389/fpubh.2025.1602802},
}
Figure